Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
COVID-19 VaccinE Response in Rheumatology Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Imaging Apoptosis for Lymphoma Treatment Response
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis
- Status
- TERMINATED
- Phase
- PHASE2
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
- Status
- COMPLETED
- Phase
- PHASE2
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
- Status
- TERMINATED
- Phase
- N/A
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Venetoclax Plus Inotuzumab for B-ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Status
- RECRUITING
- Phase
- PHASE1